{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:30Z","timestamp":1791216510901,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK083256"],"award-info":[{"award-number":["DK083256"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001866"],"award-info":[{"award-number":["UL1TR001866"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R01AI127564"],"award-info":[{"award-number":["5R01AI127564"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R37AI095983"],"award-info":[{"award-number":["5R37AI095983"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-IAHU-01"],"award-info":[{"award-number":["ANR-10-IAHU-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10875-020-00803-9","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T17:03:51Z","timestamp":1592845431000},"page":"807-819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9983-2373","authenticated-orcid":false,"given":"Xiao-Fei","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Worley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darawan","family":"Rinchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bondet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puthen Veettil","family":"Jithesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Goulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Nonnotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"Rebillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Mircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"G\u00fcrtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Migaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Elanbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanwir","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy S.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aim\u00e9","family":"Ravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Lyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Munnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darragh","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Chaussabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart G","family":"Tangye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Boisson-Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Puel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"803_CR1","first-page":"1721","volume":"248","author":"J Lejeune","year":"1959","unstructured":"Lejeune J, Gautier M, Turpin R. A study of somatic chromosomes in nine infants with mongolism. CR Acad Sci. 1959;248:1721\u20132.","journal-title":"CR Acad Sci"},{"key":"803_CR2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gim.2016.127","volume":"19","author":"G de Graaf","year":"2017","unstructured":"de Graaf G, Buckley F, Skotko BG. Estimation of the number of people with down syndrome in the United States. Genet Med. 2017;19:439\u201347.","journal-title":"Genet Med"},{"key":"803_CR3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1651-2227.1975.tb03842.x","volume":"64","author":"J Oster","year":"1975","unstructured":"Oster J, Mikkelsen M, Nielsen A. Mortality and life-table in Down\u2019s syndrome. Acta Paediatr Scand. 1975;64:322\u20136.","journal-title":"Acta Paediatr Scand"},{"key":"803_CR4","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/jmg.26.12.764","volume":"26","author":"JA Bell","year":"1989","unstructured":"Bell JA, Pearn JH, Firman D. Childhood deaths in Down\u2019s syndrome. Survival curves and causes of death from a total population study in Queensland, Australia, 1976 to 1985. J Med Genet. 1989;26:764\u20138.","journal-title":"J Med Genet"},{"key":"803_CR5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/0976-9668.159983","volume":"6","author":"A Nagarajan","year":"2015","unstructured":"Nagarajan A, Panda A, Behura SS, Mohiddin G, Narayanaswamy AB, Masthan KMK. Oral Candidal and Streptococcal carriage in Down syndrome patients. J Nat Sci Biol Med. 2015;6:300\u20135.","journal-title":"J Nat Sci Biol Med"},{"key":"803_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2133.2002.04741.x","volume":"147","author":"C Scully","year":"2002","unstructured":"Scully C, van Bruggen W, Diz Dios P, Casal B, Porter S, Davison MF. Down syndrome: lip lesions (angular stomatitis and fissures) and Candida albicans. Br J Dermatol. 2002;147:37\u201340.","journal-title":"Br J Dermatol"},{"key":"803_CR7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2214\/ajr.183.1.1830175","volume":"183","author":"LF Donnelly","year":"2004","unstructured":"Donnelly LF, Shott SR, LaRose CR, Chini BA, Amin RS. Causes of persistent obstructive sleep apnea despite previous tonsillectomy and adenoidectomy in children with down syndrome as depicted on static and dynamic cine MRI. Am J Roentgenol. 2004;183:175\u201381.","journal-title":"Am J Roentgenol"},{"key":"803_CR8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2230.2006.02164.x","volume":"31","author":"V Madan","year":"2006","unstructured":"Madan V, Williams J, Lear JT. Dermatological manifestations of Down\u2019s syndrome. Clin Exp Dermatol. 2006;31:623\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"803_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096868","volume":"9","author":"TJ Pikora","year":"2014","unstructured":"Pikora TJ, Bourke J, Bathgate K, Foley KR, Lennox N, Leonard H. Health conditions and their impact among adolescents and young adults with down syndrome. PLoS One. 2014;9:e96868.","journal-title":"PLoS One"},{"key":"803_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","volume":"164","author":"G Ram","year":"2011","unstructured":"Ram G, Chinen J. Infections and immunodeficiency in down syndrome. Clin Exp Immunol. 2011;164:9\u201316.","journal-title":"Clin Exp Immunol"},{"key":"803_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1754-4505.2011.00211.x","volume":"31","author":"J Abanto","year":"2011","unstructured":"Abanto J, Ciamponi AL, Francischini E, Murakami C, de Rezende NPM, Gallottini M. Medical problems and oral care of patients with down syndrome: a literature review. Spec Care Dentist. 2011;31:197\u2013203.","journal-title":"Spec Care Dentist"},{"key":"803_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1439-0507.2004.00968.x","volume":"47","author":"EL Svejgaard","year":"2004","unstructured":"Svejgaard EL, Nilsson J. Onychomycosis in Denmark: prevalence of fungal nail infection in general practice. Mycoses. 2004;47:131\u20135.","journal-title":"Mycoses"},{"key":"803_CR13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jiac.2015.08.002","volume":"21","author":"JN Johnston","year":"2015","unstructured":"Johnston JN, Kaplan SL, Mason EO, Hulten KG. Characterization of Staphylococcus aureus infections in children with down syndrome. J Infect Chemother. 2015;21:790\u20134.","journal-title":"J Infect Chemother"},{"key":"803_CR14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bjid.2013.05.002","volume":"17","author":"W Eldars","year":"2013","unstructured":"Eldars W, Eldegla H, Yahia S, Ela MA, Hawas S. Prevalence of community acquired infections in down syndrome children: a single center study. Braz J Infect Dis. 2013;17:624\u20135.","journal-title":"Braz J Infect Dis"},{"key":"803_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2340\/00015555-3095","volume":"99","author":"F Poizeau","year":"2019","unstructured":"Poizeau F, Sbidian E, Mircher C, Rebillat AS, Chosidow O, Wolkenstein P, et al. Prevalence and description of hidradenitis suppurativa in down syndrome: a cross-sectional study of 783 subjects. Acta Derm Venereol. 2019;99:351\u20132.","journal-title":"Acta Derm Venereol"},{"issue":"361\u2013364","key":"803_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1590\/1984-0462\/;2017;35;3;00014","volume":"35","author":"MR Romanio","year":"2017","unstructured":"Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. FUNGEMIA POR SACCHAROMYCES CEREVISIAE EM PACIENTE PEDI\u00c1TRICO AP\u00d3S TRATAMENTO COM PROBI\u00d3TICO. Rev Paul Pediatr. 2017;35(361\u2013364):361\u20134.","journal-title":"Rev Paul Pediatr"},{"issue":"34\u20135","key":"803_CR17","first-page":"43","volume":"87","author":"S Shetty","year":"2008","unstructured":"Shetty S, Kini U, Joy R. Isolated lingual mucormycosis in an infant with Down syndrome. Ear Nose Throat J. 2008;87(34\u20135):43.","journal-title":"Ear Nose Throat J"},{"key":"803_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/ajmg.a.38219","volume":"173","author":"J Lavigne","year":"2017","unstructured":"Lavigne J, Sharr C, Elsharkawi I, Ozonoff A, Baumer N, Brasington C, et al. Thyroid dysfunction in patients with down syndrome: results from a multi-institutional registry study. Am J Med Genet Part A. 2017;173:1539\u201345. https:\/\/doi.org\/10.1002\/ajmg.a.38219.","journal-title":"Am J Med Genet Part A"},{"key":"803_CR19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdcr.2019.02.007","volume":"5","author":"AL Rachubinski","year":"2019","unstructured":"Rachubinski AL, Estrada BE, Norris D, Dunnick CA, Boldrick JC, Espinosa JM. Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata. JAAD Case Rep. 2019;5:365\u20137.","journal-title":"JAAD Case Rep"},{"key":"803_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12887-017-0801-4","volume":"17","author":"JF Ludvigsson","year":"2017","unstructured":"Ludvigsson JF, Lebwohl B, Green PHR, Chung WK, M\u00e5rild K. Celiac disease and Down syndrome mortality: a nationwide cohort study. BMC Pediatr. 2017;17:41.","journal-title":"BMC Pediatr"},{"key":"803_CR21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrg1448","volume":"5","author":"SE Antonarakis","year":"2004","unstructured":"Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S. Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet. 2004;5:725\u201338.","journal-title":"Nat Rev Genet"},{"key":"803_CR22","first-page":"1289","volume":"16","author":"R F\u00f6lster-Holst","year":"2018","unstructured":"F\u00f6lster-Holst R, Rohrer T, Jung AM. Dermatological aspects of the S2k guidelines on Down syndrome in childhood and adolescence. JDDG - J Ger Soc Dermatol. 2018;16:1289\u201395.","journal-title":"JDDG - J Ger Soc Dermatol"},{"key":"803_CR23","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jpeds.2005.07.022","volume":"147","author":"YCM De Hingh","year":"2005","unstructured":"De Hingh YCM, et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr. 2005;147:744\u20137.","journal-title":"J Pediatr"},{"key":"803_CR24","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127:3154\u201364.","journal-title":"Blood"},{"key":"803_CR25","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"208","author":"L Liu","year":"2011","unstructured":"Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208:1635\u201348.","journal-title":"J Exp Med"},{"key":"803_CR26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","volume":"12","author":"A Puel","year":"2012","unstructured":"Puel A, Cypowyj S, Mar\u00f3di L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012;12:616\u201322.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"803_CR27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","volume":"365","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LAB, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365:54\u201361.","journal-title":"N Engl J Med"},{"key":"803_CR28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","volume":"6","author":"EC Borden","year":"2007","unstructured":"Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov. 2007;6:975\u201390.","journal-title":"Nat Rev Drug Discov"},{"key":"803_CR29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/science.186.4158.61","volume":"186","author":"YH Tan","year":"1974","unstructured":"Tan YH, Schneider EL, Tischfield J, Epstein CJ, Ruddle FH. Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state. Science. 1974;186:61\u20133.","journal-title":"Science"},{"key":"803_CR30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/267165a0","volume":"267","author":"CG Cupples","year":"1977","unstructured":"Cupples CG, Tan YH. Effect of human interferon preparations on lymphoblastogenesis in Down\u2019s syndrome. Nature. 1977;267:165\u20137.","journal-title":"Nature"},{"key":"803_CR31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/519248","volume":"81","author":"P Prandini","year":"2007","unstructured":"Prandini P, Deutsch S, Lyle R, Gagnebin M, Vivier CD, Delorenzi M, et al. Natural gene-expression variation in down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet. 2007;81:252\u201363.","journal-title":"Am J Hum Genet"},{"key":"803_CR32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16220","volume":"5","author":"KD Sullivan","year":"2016","unstructured":"Sullivan KD, Lewis HC, Hill AA, Pandey A, Jackson LP, Cabral JM, et al. Trisomy 21 consistently activates the interferon response. Elife. 2016;5:e16220.","journal-title":"Elife"},{"key":"803_CR33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/hmg\/dds484","volume":"22","author":"XF Kong","year":"2013","unstructured":"Kong XF, Vogt G, Itan Y, Macura-Biegun A, Szaflarska A, Kowalczyk D, et al. Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. Hum Mol Genet. 2013;22:769\u201381.","journal-title":"Hum Mol Genet"},{"key":"803_CR34","first-page":"5896","volume":"116","author":"XF Kong","year":"2010","unstructured":"Kong XF, et al. A novel form of human STAT1 deficiency impairing early but not late responses to interferons. Blood. 2010;116:5896\u2013906.","journal-title":"Blood"},{"key":"803_CR35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/hmg\/ddp507","volume":"19","author":"XF Kong","year":"2010","unstructured":"Kong XF, Vogt G, Chapgier A, Lamaze C, Bustamante J, Prando C, et al. A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon. Hum Mol Genet. 2010;19:434\u201344.","journal-title":"Hum Mol Genet"},{"key":"803_CR36","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20161451","volume":"214","author":"MP Rodero","year":"2017","unstructured":"Rodero MP, Decalf J, Bondet V, Hunt D, Rice GI, Werneke S, et al. Detection of interferon alpha protein reveals differential levels and cellular sources in disease. J Exp Med. 2017;214:1547\u201355.","journal-title":"J Exp Med"},{"key":"803_CR37","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","volume":"12","author":"GI Rice","year":"2013","unstructured":"Rice GI, Forte GMA, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS, et al. Assessment of interferon-related biomarkers in Aicardi-Gouti\u00e8res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol. 2013;12:1159\u201369.","journal-title":"Lancet Neurol"},{"key":"803_CR38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.immuni.2012.12.008","volume":"38","author":"G Obermoser","year":"2013","unstructured":"Obermoser G, Presnell S, Domico K, Xu H, Wang Y, Anguiano E, et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity. 2013;38:831\u201344.","journal-title":"Immunity"},{"key":"803_CR39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.immuni.2008.05.012","volume":"29","author":"D Chaussabel","year":"2008","unstructured":"Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity. 2008;29:150\u201364.","journal-title":"Immunity"},{"key":"803_CR40","doi-asserted-by":"publisher","unstructured":"Ottaviano G, et al. A prevalent CXCR3+ phenotype of circulating follicular helper T cells indicates humoral dysregulation in children with Down syndrome. J Clin Immunol. 2020:1\u20139. https:\/\/doi.org\/10.1007\/s10875-020-00755-0.","DOI":"10.1007\/s10875-020-00755-0"},{"key":"803_CR41","doi-asserted-by":"crossref","first-page":"24231","DOI":"10.1073\/pnas.1908129116","volume":"116","author":"P Araya","year":"2019","unstructured":"Araya P, Waugh KA, Sullivan KD, N\u00fa\u00f1ez NG, Roselli E, Smith KP, et al. Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity. Proc Natl Acad Sci U S A. 2019;116:24231\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"803_CR42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature13200","volume":"508","author":"A Letourneau","year":"2014","unstructured":"Letourneau A, Santoni FA, Bonilla X, Sailani MR, Gonzalez D, Kind J, et al. Domains of genome-wide gene expression dysregulation in Down\u2019s syndrome. Nature. 2014;508:345\u201350.","journal-title":"Nature"},{"key":"803_CR43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1095-177","volume":"11","author":"RH Reeves","year":"1995","unstructured":"Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, et al. A mouse model for down syndrome exhibits learning and behaviour deficits. Nat Genet. 1995;11:177\u201384.","journal-title":"Nat Genet"},{"key":"803_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2017.00119","volume":"8","author":"M Syedbasha","year":"2017","unstructured":"Syedbasha M, Egli A. Interferon lambda: modulating immunity in infectious diseases. Front Immunol. 2017;8:119.","journal-title":"Front Immunol"},{"key":"803_CR45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ncb3312","volume":"18","author":"A Fatehullah","year":"2016","unstructured":"Fatehullah A, Tan SH, Barker N. Organoids as an in vitro model of human development and disease. Nat Cell Biol. 2016;18:246\u201354.","journal-title":"Nat Cell Biol"},{"key":"803_CR46","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","volume":"213","author":"MP Rodero","year":"2016","unstructured":"Rodero MP, Crow YJ. Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med. 2016;213:2527\u201338.","journal-title":"J Exp Med"},{"key":"803_CR47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","volume":"197","author":"L Bennett","year":"2003","unstructured":"Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003;197:711\u201323.","journal-title":"J Exp Med"},{"key":"803_CR48","doi-asserted-by":"publisher","unstructured":"Altman MC et al. A novel repertoire of blood transcriptome modules based on co-expression patterns across sixteen disease and physiological states. bioRxiv 525709 (2019). https:\/\/doi.org\/10.1101\/525709","DOI":"10.1101\/525709"},{"key":"803_CR49","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","volume":"166","author":"S Meyer","year":"2016","unstructured":"Meyer S, Woodward M, Hertel C, Vlaicu P, Haque Y, K\u00e4rner J, et al. AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies. Cell. 2016;166:582\u201395.","journal-title":"Cell"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00803-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00803-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00803-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T23:43:49Z","timestamp":1624319029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00803-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["803"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00803-9","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"15 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Casanova reports personal fees from Celgene, personal fees from ADMA, personal fees from Nimbus, personal fees from Vitae Pharmaceuticals, Inc., personal fees from KymeraTX, personal fees from Sanofi, personal fees from Asahi Kasei, personal fees from Pfizer, personal fees from Elixiron Immunotherapeutics, outside the submitted work. The other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}